Retroviral RLI/4-1 BBL and RLI/FLT3L Combination Immunomodulatory Gene Therapy for Glioblastoma

逆转录病毒 RLI/4-1 BBL 和 RLI/FLT3L 联合免疫调节基因治疗胶质母细胞瘤

• 批准号: 10740288
• 负责人: Manish Aghi
• 金额: $ 9.5万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-02-15 至 2023-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10740288
• 关键词: Award; FLT3 ligand; Glioblastoma; Parents; Research; career; gene therapy; immunoregulation; parent grant; Award; FLT3 ligand; Glioblastoma; Parents; Research; career; gene therapy; immunoregulation; parent grant

PROJECT SUMMARY/ABSTRACT This proposed project is within the scope of R01NS123808. There are no changes to the Project Summary/Narrative of the Parent Award. A brief description of the Parent Grant Specific Aims is provided within the Research and Career Plan.

项目摘要/摘要 该提议的项目在R01NS123808的范围内。项目没有变化 父母奖的摘要/叙述。提供了父母赠款特定目标的简要说明 在研究和职业计划中。